Production of low fucose antibodies in h4-ii-e rat cells
AssigneeBoehringer Ingelheim International GmbH
InventorsKristina Ellwanger, Lore Florin, Hitto Kaufmann
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorsKristina Ellwanger, Lore Florin, Hitto Kaufmann
Estimating the term…
The invention concerns the field of cell culture technology. It specifically concerns a rat hepatoma cell, preferably a H4-II-E rat hepatoma cell, carrying a DNA encoding an antibody or Fc-fusion protein and having low fucosylation activity for adding fucose to glycosidic structures such as biantennary glycans, e.g. N-acetylglucosamine. The invention furthermore concerns a method for producing low fucose glycoproteins especially antibodies or Fc-fusion proteins in rat hepatoma cells, preferably in H4-II-E rat hepatoma cells. It further concerns the identification and generation of new host cell lines which are capable of synthetizing glycoproteins with beneficial properties, improving the therapeutic efficacy and/or serum half-life of the product compared to products from commonly used host cell lines.
A rat hepatoma cell comprising a nucleic acid sequence encoding an antibody or Fc-fusion protein, wherein said nucleic acid sequence is operatively linked to at least one regulatory sequence allowing for expression of said nucleic acid sequence encoding an antibody or Fc-fusion protein.
A method for producing a glycoprotein of interest comprising the steps of:
A method for producing a (recombinant) antibody or Fc-fusion protein having
A method of generating a host cell for production of recombinant glycoprotein comprising:
A (rat hepatoma) cell deposited with the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH) under the accession number DSM ACC3130 (H4-II-Es).
Dependencies are inferred from the claim text.